Nuclear Medicine Market - By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes) By Application (Diagnostic Applications, PET Applications, Therapeutic Applications) By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures) By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 181
Status: Published
Report Code: ARI100578
Furthermore, increasing demand for proper healthcare infrastructure, the non-invasive nature of the process and increasing investment on healthcare in this growing country is likely to upsurge the demand of this market, positively. The nuclear medicine and radiopharmaceuticals market is further driven by spreading awareness at global level, major progress in development of the radiotracers and the new pipeline of radioisotopes. On the other hand, very short term life of the radiopharmaceuticals, unavailability of the reimbursement policy and strict policy and rule are some of the factor hampering the growth of the market at global level. The radiation exposure side effects is also one of the important factor driving the demand negatively. The major side effects of the radiation are infertility among men, skin irritation, vomiting, fatigue and nausea.
The global market for nuclear medicine and radiopharmaceuticals can be classified on the basis of the product types and applications. Among all segment, cardiology of the application segments dominates the market in terms of largest market share. Whereas, SPECT of the product types segments expected to account for major share of the market in nuclear medicine and radio pharmaceuticals market in coming years.
Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).
Analyst Commentary
Growth in the nuclear medicine market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
On the basis of type, SPECT dominated the market for nuclear medicine in 2020 owing to low cost and wide usage in different applications. Furthermore, digital SPECT scanners are being introduced in the market for nuclear medicine by key players to improve diagnosis. For instance, in November 2018, Spectrum Dynamics received U.S. FDA approval for VERITON-CT 64 SPECT/CT system offering more image detail and a 360 degree multi-detector geometry to yield high sensitivity.
On the basis of application, Cardiology is expected to be the fastest growing segment during the forecast period owing to the low cost of techniques and high adoption rate.
On the basis of procedural volume assessment, Diagnostic procedures account for the larger share, as diagnostic radioisotopes find wider demand and use as compared to therapeutic radioisotopes. Since the introduction of nuclear medicine, SPECT diagnosis has been preferred over other radiopharmaceutical procedures. Due to looming uncertainties in the production of reactor-based Mo-99, the radiopharmaceuticals market is witnessing a shift toward PET procedures. Other major factors responsible for this trend are advancements in radiotracers for PET and the advent of hybrid imaging systems such as PET-CT and PET-MRI.
Segmentation
The global radiopharmaceuticals industry is bifurcated on the basis of type, Procedural Volume Assessment, application, and geography. Based on type, the nuclear medicine market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes. Based on application, the nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The SPECT applications is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. Based on procedural volume assessment, the nuclear medicine market is segmented into diagnostic and therapeutic procedures. The geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.
Regional Analysis
North America will be the leading region during the forecast period. The North American nuclear medicine market is segmented into the US and Canada, based on country. The US is expected to register the highest CAGR during the forecast period. Development of unique technologies for the production of isotopes, presence of leading market players, and rapid uptake of new technologies will boost the market growth in this region. Europe will be the second largest market. The major reasons are presence of skilled professionals, rise in awareness regarding use of nuclear medicine, high cancer prevalence, and favourable reimbursement scenario.
The market in Asia Pacific is expected to grow at a significant rate during the forecast period. Increasing geriatric population and awareness about nuclear medicines & molecular imaging are contributing to the growth of the radiopharmaceuticals market in this region. Furthermore, this region is focusing on the development of radiopharmaceuticals for the diagnosis and treatment of various diseases. For instance, in August 2018, Indonesia’s National Nuclear Agency (BATAN), along with International Atomic Energy Agency (IAEA), developed new radiopharmaceuticals (99mTc-ethambutol) for diagnosis of tuberculosis. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Nuclear Medicine Market
Chapter 5. Global Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
5.1. Global Nuclear Medicine Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Diagnostic Nuclear Medicine
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Therapeutic Nuclear Medicine
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Brachytherapy Isotopes
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
6.1. Global Nuclear Medicine Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Diagnostic
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. PET
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Therapeutic
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Nuclear Medicine Market Overview, By Procedural Volume Assessment, 2015 - 2027(USD Million)
7.1. Global Nuclear Medicine Market Share, By Procedural Volume Assessment, 2015 - 2027 (USD Million)
7.1.1. Diagnostic Procedures
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Therapeutic Procedures
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Nuclear Medicine Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Nuclear Medicine Market Share, By Geography, 2015 - 2027(USD Million)
8.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Nuclear Medicine Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.2. North America Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. North America Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. North America Nuclear Medicine Market Overview, By Procedural Volume Assessment, 2015 - 2027 (USD Million)
9.1.5. North America Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Nuclear Medicine Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Europe Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Europe Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
10.1.5. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.1.3. Germany Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.2.3. France Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.3.3. UK Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.4.3. Italy Nuclear Medicine Market Overview, By Application 2015 - 2027(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.5.3. Spain Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Type and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.6.3. Rest of Europe Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
11.1.5. Asia Pacific Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.1.3. India Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Type and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.2.3. China Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Nuclear Medicine Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Type and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Nuclear Medicine Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Nuclear Medicine Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Nuclear Medicine Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.2. South America Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.3. South America Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.4. South America Nuclear Medicine Market Overview, By Procedural Volume Assessment,2015 - 2027 (USD Million)
13.1.5. South America Nuclear Medicine Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.6.2. Brazil Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.6.3. Brazil Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.7.2. Argentina Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.7.3. Argentina Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Type and projections, 2015 – 2027
13.1.8.2. Rest of South America Nuclear Medicine Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.8.3. Rest of South America Nuclear Medicine Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Type development
Chapter 15. Key Vendor Analysis
15.1. Cardinal Health
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Curium
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. GE Healthcare
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Lantheus Medical Imaging, Inc.
15.5. Bayer AG
15.6. Bracco Imaging S.P.A.
15.7. Eczacibasi-Monrol Nuclear Products
15.8. Nordion, Inc.
15.9. Advanced Accelerator Applications
15.10. NTP Radioisotopes Soc, LTD.
Chapter 16. Nuclear Medicine Market Cost Analysis
16.1. Nuclear Medicine Market Key Type Analysis
16.1.1. Key Type
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers of Type
16.1.4. Market Concentration Rate of Type
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Nuclear Medicine Market Chain Analysis
17.2. Upstream Type Sourcing
17.3. Nuclear Medicine Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Type
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Nuclear Medicine Market share, By Type, 2020 & 2027 (%)
10. Global Nuclear Medicine Market share, by Diagnostic Nuclear Medicine, By Type, 2015 - 2027 (USD Million)
11. Global Nuclear Medicine Market share, by Therapeutic Nuclear Medicine, By Type, 2015 - 2027 (USD Million)
12. Global Nuclear Medicine Market share, by Brachytherapy Isotopes, By Type, 2015 - 2027 (USD Million)
13. Global Nuclear Medicine Market share, By Application, 2020 & 2027 (%)
14. Global Nuclear Medicine Market share, by Diagnostic, By Application, 2015 - 2027 (USD Million)
15. Global Nuclear Medicine Market share, by PET, By Application 2015 - 2027 (USD Million)
16. Global Nuclear Medicine Market share, by Therapeutic, By Application 2015 - 2027 (USD Million)
17. Global Nuclear Medicine Market share, By Procedural Volume Assessment, 2020 & 2027 (%)
18. Global Nuclear Medicine Market share, by Diagnostic Procedures, By Procedural Volume Assessment, 2015 - 2027 (USD Million)
19. Global Nuclear Medicine Market share, by Therapeutic Procedures, By Procedural Volume Assessment 2015 - 2027 (USD Million)
20. Global Nuclear Medicine Market share, by region, 2020 & 2027 (%)
21. Global Nuclear Medicine Market share, by region, 2015 - 2027(USD Million)
22. North America Nuclear Medicine Market, 2015 - 2027(USD Million)
23. North America Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
24. U.S. Nuclear Medicine Market, 2015 - 2027(USD Million)
25. Canada Nuclear Medicine Market, 2015 - 2027(USD Million)
26. Mexico Nuclear Medicine Market, 2015 - 2027(USD Million)
27. Europe Nuclear Medicine Market, 2015 - 2027(USD Million)
28. Europe Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
29. Spain Nuclear Medicine Market, 2015 - 2027(USD Million)
30. UK Nuclear Medicine Market, 2015 - 2027(USD Million)
31. Italy Nuclear Medicine Market, 2015 - 2027(USD Million)
32. Germany Nuclear Medicine Market, 2015 - 2027(USD Million)
33. France Nuclear Medicine Market, 2015 - 2027(USD Million)
34. Rest of Europe Nuclear Medicine Market, 2015 - 2027(USD Million)
35. Asia-Pacific Nuclear Medicine Market, 2015 - 2027(USD Million)
36. Asia-Pacific Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
37. China Nuclear Medicine Market, 2015 - 2027(USD Million)
38. India Nuclear Medicine Market, 2015 - 2027(USD Million)
39. Australia Nuclear Medicine Market, 2015 - 2027(USD Million)
40. Japan Nuclear Medicine Market, 2015 - 2027(USD Million)
41. Rest of Asia-Pacific Nuclear Medicine Market, 2015 - 2027(USD Million)
42. Middle East & Africa Nuclear Medicine Market, 2015 - 2027(USD Million)
43. Middle East & Africa Nuclear Medicine Market share, by Countries, 2020 & 2027 (%)
44. GCC Nuclear Medicine Market, 2015 - 2027(USD Million)
45. South Africa Nuclear Medicine Market, 2015 - 2027(USD Million)
46. Rest Of Middle East & Africa Nuclear Medicine Market, 2015 - 2027(USD Million)
47. South America Nuclear Medicine Market, 2015 - 2027(USD Million)
48. Brazil Nuclear Medicine Market, 2015 - 2027(USD Million)
49. Mexico Nuclear Medicine Market, 2015 - 2027(USD Million)
50. Argentina Nuclear Medicine Market, 2015 - 2027(USD Million)
51. Rest Of South America Nuclear Medicine Market, 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Nuclear Medicine Market, 2015-2027 (USD Million)
4. Nuclear Medicine requirement, by country, 2015-2027, (USD Million)
5. North America Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
6. North America Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
7. North America Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
8. Europe Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
9. Europe Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
10. Europe Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
11. Asia Pacific Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
12. Asia Pacific Nuclear Medicine Market, By Application, 2015-2027 (Revenue, USD Million)
13. Asia Pacific Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (Revenue, USD Million)
14. Middle East & Africa Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
15. Middle East & Africa Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
16. Middle East & Africa Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
17. South America Nuclear Medicine Market, By Type, 2015-2027 (USD Million)
18. South America Nuclear Medicine Market, By Application, 2015-2027 (USD Million)
19. South America Nuclear Medicine Market, By Procedural Volume Assessment, 2015-2027 (USD Million)
20. Global Nuclear Medicine Market, Company Market Share, 2020 - 2027 (%)
21. Cardinal Health : Deployment model Benchmarking
22. Cardinal Health : Financial Performance
23. Curium : Deployment model Benchmarking
24. Curium : Financial Performance
25. GE Healthcare: Deployment model Benchmarking
26. GE Healthcare : Financial Performance
27. Lantheus Medical Imaging, Inc.: Deployment model Benchmarking
28. Lantheus Medical Imaging, Inc.: Financial Performance
29. Bayer AG :Deployment model Benchmarking
30. Bayer AG : Financial Performance
31. Bracco Imaging S.P.A. : Deployment model Benchmarking
32. Bracco Imaging S.P.A. : Financial Performance
33. Eczacibasi-Monrol Nuclear Products : Product Benchmarking
34. Eczacibasi-Monrol Nuclear Products : Financial Performance
35. Nordion, Inc.: Product Benchmarking
36. Nordion, Inc.: Financial Performance
37. Advanced Accelerator Applications : Product Benchmarking
38. Advanced Accelerator Applications : Financial Performance
39. NTP Radioisotopes Soc, LTD. : Product Benchmarking
40. NTP Radioisotopes Soc, LTD. : Financial Performance
The Leading Key Players in Nuclear Medicine Market
Cardinal Health (US)
GE Healthcare (US)
Curium (France)
Lantheus Medical Imaging (US)
Bayer AG (Germany)
Bracco Imaging (Italy)
Eczacýbaþý-Monrol Nuclear Products (Turkey)
Nordion (Canada)
Advanced Accelerator Applications (France)
NTP Radioisotopes (South Africa).
